8-K
filed May 10, 2023, 7:59 PM ET
ticker PIII
CIK 0001832511
earnings
confidence high
sentiment positive
materiality 0.75
P3 Q1 capitated revenue up 11%; net loss improves 14%; medical margin surges 58%
P3 Health Partners Inc.
2023-Q1 EPS reported
-$0.22
revenue$302,077,000
- Capitated revenue $298.7M (+11% YoY); net loss $52.4M, improved from $60.8M in Q1 2022.
- Medical margin $39.2M (13.1% of capitated revenue), up 58% YoY; network contribution $16.5M (+114%).
- Adjusted EBITDA loss $19.1M; full-year guidance raised to loss $35-55M from prior expectations.
- FY 2023 guidance: revenue $1.2-1.25B, medical margin $155-175M, members 115k-120k.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
P3 Health Partners Inc. reported the first quarter ended March 31, 2023 results: revenue $298.7 million, net income $52.4 million.
- Period
- the first quarter ended March 31, 2023
- Revenue
- $298.7 million
- Net income
- $52.4 million
- Result
- reported results
Exact text from the filing
a model where we believe the patient, providers, payors and ultimately our shareholders win,” Dr. Abdou concluded. First Quarter 2023 Financial Results • Capitated revenue was $298.7 million, an increase of 11% compared to $269.7 million in the first quarter of the prior year, and an increase of 18% compared to the fourth quarter of 2022 • Net loss was $52.4 million,
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
P3 Health Partners Inc. reported year ending December 31, 2023 results: revenue $ 1,200 $ 1,250. Guidance raised.
- Period
- year ending December 31, 2023
- Revenue
- $ 1,200 $ 1,250
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
of 250% compared to fourth quarter of 2022 Full-Year 2023 Guidance Year Ended December 31, 2023 Low High Medicare Advantage Members 115,000 120,000 Total Revenues (in millions) $ 1,200 $ 1,250 Medical margin (2) (in millions) $ 155 $ 175 Medical margin (2) PMPM $ 120 $ 130 Adjusted EBITDA (2) Loss (in millions) $ (55) $ (35) (1) Adjusted EBITDA, Adjusted EBITDA
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.